Company Update (NYSE:COV): Medtronic seeks EU approval for $43 bln Covidien deal

[Reuters - UK Focus] – U.S. medical equipment maker Medtronic has asked European Union antitrust regulators to approve its proposed $43 billion purchase of Irish peer Covidien Plc, the European Commission said on . . . → Read More: Company Update (NYSE:COV): Medtronic seeks EU approval for $43 bln Covidien deal Similar Articles: Market Update: Medtronic Inc (NYSE:MDT) – Medtronic seeks EU approval for $43 bln Covidien deal Company Update (NYSE:COV): Covidien Acquires Reverse Medical Corporation Company Update: Covidien plc (NYSE:COV) – Covidien Opens Advanced Medical Technology Center in Brazil